These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25448412)

  • 1. Ubiquitination of the transcription factor c-MAF is mediated by multiple lysine residues.
    Chen G; Xu X; Tong J; Han K; Zhang Z; Tang J; Li S; Yang C; Li J; Cao B; Zhou H; Wu D; Moran MF; Mao X
    Int J Biochem Cell Biol; 2014 Dec; 57():157-66. PubMed ID: 25448412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ubiquitin-conjugating enzyme UBE2O modulates c-Maf stability and induces myeloma cell apoptosis.
    Xu Y; Zhang Z; Li J; Tong J; Cao B; Taylor P; Tang X; Wu D; Moran MF; Zeng Y; Mao X
    J Hematol Oncol; 2017 Jul; 10(1):132. PubMed ID: 28673317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ubiquitin ligase HERC4 mediates c-Maf ubiquitination and delays the growth of multiple myeloma xenografts in nude mice.
    Zhang Z; Tong J; Tang X; Juan J; Cao B; Hurren R; Chen G; Taylor P; Xu X; Shi CX; Du J; Hou J; Wang G; Wu D; Stewart AK; Schimmer AD; Moran MF; Mao X
    Blood; 2016 Mar; 127(13):1676-86. PubMed ID: 26825710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the deubiquitinase USP5 leads to c-Maf protein degradation and myeloma cell apoptosis.
    Wang S; Juan J; Zhang Z; Du Y; Xu Y; Tong J; Cao B; Moran MF; Zeng Y; Mao X
    Cell Death Dis; 2017 Sep; 8(9):e3058. PubMed ID: 28933784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A chemical biology screen identifies glucocorticoids that regulate c-maf expression by increasing its proteasomal degradation through up-regulation of ubiquitin.
    Mao X; Stewart AK; Hurren R; Datti A; Zhu X; Zhu Y; Shi C; Lee K; Tiedemann R; Eberhard Y; Trudel S; Liang S; Corey SJ; Gillis LC; Barber DL; Wrana JL; Ezzat S; Schimmer AD
    Blood; 2007 Dec; 110(12):4047-54. PubMed ID: 17875808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mebendazole elicits potent antimyeloma activity by inhibiting the USP5/c-Maf axis.
    Chen XH; Xu YJ; Wang XG; Lin P; Cao BY; Zeng YY; Wang Q; Zhang ZB; Mao XL; Zhang T
    Acta Pharmacol Sin; 2019 Dec; 40(12):1568-1577. PubMed ID: 31197245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transmembrane protein TMEPAI induces myeloma cell apoptosis by promoting degradation of the c-Maf transcription factor.
    Du Y; Liu Y; Xu Y; Juan J; Zhang Z; Xu Z; Cao B; Wang Q; Zeng Y; Mao X
    J Biol Chem; 2018 Apr; 293(16):5847-5859. PubMed ID: 29467225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival.
    He Y; Wang S; Tong J; Jiang S; Yang Y; Zhang Z; Xu Y; Zeng Y; Cao B; Moran MF; Mao X
    J Biol Chem; 2020 Feb; 295(7):2084-2096. PubMed ID: 31822558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of major lysine residues of S(3)-RNase of Petunia inflata involved in ubiquitin-26S proteasome-mediated degradation in vitro.
    Hua Z; Kao TH
    Plant J; 2008 Jun; 54(6):1094-104. PubMed ID: 18346191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical role of lysine 123 in the ubiquitin-mediated degradation of MDA-7/IL-24.
    Tian H; Li L; Zhang B; Di J; Chen F; Li H; Liu J; Pei D; Zheng J
    J Interferon Cytokine Res; 2012 Dec; 32(12):575-82. PubMed ID: 23078624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUMOylation negatively regulates transcriptional and oncogenic activities of MafA.
    Kanai K; Reza HM; Kamitani A; Hamazaki Y; Han SI; Yasuda K; Kataoka K
    Genes Cells; 2010 Sep; 15(9):971-82. PubMed ID: 20718938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteasomal degradation of ubiquitinated Insig proteins is determined by serine residues flanking ubiquitinated lysines.
    Lee JN; Gong Y; Zhang X; Ye J
    Proc Natl Acad Sci U S A; 2006 Mar; 103(13):4958-63. PubMed ID: 16549805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDA-7/IL-24, a novel tumor suppressor/cytokine is ubiquitinated and regulated by the ubiquitin-proteasome system, and inhibition of MDA-7/IL-24 degradation enhances the antitumor activity.
    Gopalan B; Shanker M; Scott A; Branch CD; Chada S; Ramesh R
    Cancer Gene Ther; 2008 Jan; 15(1):1-8. PubMed ID: 17828282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single mutation at lysine 241 alters expression and trafficking of the D2 dopamine receptor.
    Kim OJ
    J Recept Signal Transduct Res; 2008; 28(5):453-64. PubMed ID: 18946766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAF protein mediates innate resistance to proteasome inhibition therapy in multiple myeloma.
    Qiang YW; Ye S; Chen Y; Buros AF; Edmonson R; van Rhee F; Barlogie B; Epstein J; Morgan GJ; Davies FE
    Blood; 2016 Dec; 128(25):2919-2930. PubMed ID: 27793878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteome-wide identification of ubiquitylation sites by conjugation of engineered lysine-less ubiquitin.
    Oshikawa K; Matsumoto M; Oyamada K; Nakayama KI
    J Proteome Res; 2012 Feb; 11(2):796-807. PubMed ID: 22053931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the Otub1/c-Maf axis for the treatment of multiple myeloma.
    Xu Y; Xu M; Tong J; Tang X; Chen J; Chen X; Zhang Z; Cao B; Stewart AK; Moran MF; Wu D; Mao X
    Blood; 2021 Mar; 137(11):1478-1490. PubMed ID: 32842143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysine-independent turnover of cyclin G1 can be stabilized by B'alpha subunits of protein phosphatase 2A.
    Li H; Okamoto K; Peart MJ; Prives C
    Mol Cell Biol; 2009 Feb; 29(3):919-28. PubMed ID: 18981217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ARK5 is transcriptionally regulated by the Large-MAF family and mediates IGF-1-induced cell invasion in multiple myeloma: ARK5 as a new molecular determinant of malignant multiple myeloma.
    Suzuki A; Iida S; Kato-Uranishi M; Tajima E; Zhan F; Hanamura I; Huang Y; Ogura T; Takahashi S; Ueda R; Barlogie B; Shaughnessy J; Esumi H
    Oncogene; 2005 Oct; 24(46):6936-44. PubMed ID: 16044163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of primary MAFB target genes in multiple myeloma.
    van Stralen E; van de Wetering M; Agnelli L; Neri A; Clevers HC; Bast BJ
    Exp Hematol; 2009 Jan; 37(1):78-86. PubMed ID: 19013005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.